Phase I/II clinical trial of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma Meeting Abstract
| Authors: | Batlevi, C. L.; De Frank, S.; Stewart, C.; Hamlin, P. A.; Matasar, M. J.; Gerecitano, J. F.; Moskowitz, A. J.; Hamilton, A. M.; Zelenetz, A. D.; Drullinsky, P.; Straus, D. J.; Kumar, A.; Moskowitz, C. H.; Dicostanzo, J.; Callan, D.; Tsui, D.; Rademaker, J.; Schoder, H.; Ni, A.; Younes, A. |
| Abstract Title: | Phase I/II clinical trial of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 404s |
| Language: | English |
| ACCESSION: | WOS:000442916002590 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.7520 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 7520 -- Source: Wos |
